ARCA biopharma's competitors

ARCA biopharma's competitors include Lexicon Pharmaceuticals, Sarepta Therapeutics, Vical and Ultragenyx Pharmaceutical
Add company...
ARCA biopharma
ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Vical
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Founding Date
Founding Date
2009
Founding Date
1995
Founding Date
1980
Founding Date
1987
Founding Date
2010
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Westminster, US HQ
Aurora, US
Westminster, US
Locations
Spring, US HQ
Jersey, JE
Indianapolis, US
The Woodlands, US
Boston, US
Chicago, US
Philadelphia, US
see more
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Locations
Novato, US HQ
Employees
Employees
20
Employees
168
Employees
197
Employees
73
Employees
376
Valuation ($)
Valuation ($)
18.2 m
Valuation ($)
873.2 m
Valuation ($)
3.9 b
Valuation ($)
17 m
Valuation ($)
2 b
Twitter followers
Twitter followers
N/A
Twitter followers
104
Twitter followers
208
Twitter followers
65
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$83.3m (FY, 2016)
Revenue (est.)
$5.4m (FY, 2016)
Revenue (est.)
$14.5m (FY, 2016)
Revenue (est.)
$133k (FY, 2016)
Net income
Net income
($16.4m) (FY, 2016)
Net income
($141.4m) (FY, 2016)
Net income
($267.3m) (FY, 2016)
Net income
($9m) (FY, 2016)
Net income
($245.9m) (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles